Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Low grade lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 3
This trial is looking at ibrutinib with bendamustine and rituximab for mantle cell lymphoma. The people taking part are over 65 years of age and have only recently been diagnosed with mantle cell lymphoma.
Mantle cell lymphoma is a rare type of non Hodgkin lymphoma. Doctors usually treat it with chemotherapy and a drug called rituximab.
Recruitment start: 1 June 2013
Recruitment end: 25 November 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Simon Rule
Experimental Cancer Medicine Centre (ECMC)
Janssen-Cilag
NIHR Clinical Research Network: Cancer
Last reviewed: 03 Dec 2014
CRUK internal database number: 10627
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
